Fleury S.A. (FLRY3.SA) stock: key figures, P/E, revenue and dividend
Health Care · Health Care Services · Brazil · ISIN BRFLRYACNOR5
Fleury S.A. financials
| Fiscal year | 2024 | 2025 |
|---|---|---|
| Revenue | 7.68 bn BRL | 8.29 bn BRL |
| Gross profit | 2.14 bn BRL | 1.99 bn BRL |
| Operating income | 1.20 bn BRL | 1.22 bn BRL |
| EBIT | 1.32 bn BRL | 1.22 bn BRL |
| Net income | 616.17 m BRL | 612.83 m BRL |
| Diluted EPS – continuing operations | 1.13 BRL | 1.12 BRL |
Full history since 2006, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Fleury S.A.
Fleury S.A., together with its subsidiaries, engages in the provision of diagnostic imaging, clinical analysis, fertility, and infusions services in Brazil. It operates in two segments, Diagnostic Medicine and Integrated Medicine. The company also provides medical services in the areas of diagnostics, laboratory support, infusions, clinical analyses, health management, healthcare, assistance medicine, orthopedics, ophthalmology, toxicological tests, fertility, infusions, and others. In addition, it operates a health platform, immunobiological drug infusion center, and ophthalmology service centers. Fleury S.A. was founded in 1926 and is headquartered in São Paulo, Brazil.
More stocks
- Embracer Group AB (EMBRAC B.ST)
- Hpsp Co Ltd (403870.KQ)
- Wuhu Token Sciences (300088.SZ)
- Kainos Group PLC (KNOS.L)
- Chorus Ltd (CNU.AX)
- Immunome Inc. (IMNM)
- Henan Lingrui Pharmaceutical Co Ltd (600285.SS)
- KCC Corporation (002380.KS)
- Gempharmatech Co. Ltd. A (688046.SS)
- Shenzhen Overseas Chinese Town Co Ltd (000069.SZ)
- Monadelphous Group Ltd (MND.AX)
- Teijin Ltd (3401.T)
Not investment advice. All data without warranty, price as of 30.10.2026. Details in the risk notice.